Core One Labs Inc C.COOL

Alternate Symbol(s): CLABF

Healthcare Cannabis Psychedelics

Core One Labs Inc. is a Canada-based life sciences biotechnology research and development company. The Company is focused on bringing psychedelic medicines to market through the development and production of psychedelic compounds, the advancement of psychedelic assisted treatments, and the integration of delivery systems technology. Its subsidiary, Vocan Biotechnologies Inc., has developed and filed for patent protection of a proprietary psilocybin production system using engineered bacteria. It is also the holder of four provisional patents for the development of psychedelic-based pharmaceutical formulations targeting neurological and mental health disorders, under its subsidiary Akome Biotech Ltd., and three provisional patents under its other subsidiary, Awakened Biosciences Inc., for additional synthetic technologies for psilocybin and psilocin production methods. It also holds an interest in four medical clinics, which maintain a combined database of more than 275,000 patients.

CSE:COOL - Post by User

Core One Labs Inc

Bullboard Posts

Post by thunderpigon Jan 05, 2018 9:35am

125 Views

Post# 27288458

DEC 22 NR

I think the videos in November might of been a bit confusing but its quite clear that they are only starting Production for Cannistrips Jan 1 per Dec 22 NR.

This licence marks the beginning of the most significant milestone yet in the development of the CannaStrips project. On Jan. 1, 2018, for the first time the LDS CannaStrips technology with the CSPA Group licensee and LDS Scientific Inc. consulting will be producing a product for patients that is safe, free of contaminates, with accurate dosage, delivering consistent results and licensed by the State of California."

Bullboard Posts

Global Tungsten Market and Supply Security